Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-002264
Filing Date
2022-01-18
Accepted
2022-01-18 20:39:52
Documents
1
Period of Report
2022-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4421
  Complete submission text file 0000899243-22-002264.txt   6017
Mailing Address C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 94538
Business Address
Riley Antony A (Reporting) CIK: 0001339375 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 22536543

Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations